Archive: 2025 2024 2023 2022 2021 2020 2019 2018 2017
13th of September 2021
CRC 1279 Monday Seminar series with Jessica L枚ffler
鈥淭he HET-CAM model for evaluating tumor accumulation and biodistribution of newly developed compounds using PET and MR imaging鈥�
Place: N27, Time: 15h00
20th of September 2021
CRC 1279 Monday Seminar series with Prof. Gerhard Scheuch
鈥淭he spread of SARS CoV 2 and other viruses through breathing鈥�
Place: N27, Time: 15h00
27th of September 2021
CRC 1279 Monday Seminar series with Dr. Carina de Oliveira Mann
鈥淐yclic Nucleotide Second Messenger Signaling in Antiviral Immunity鈥�
Place: N27, Time: 15h00
26th of July 2021
Dr. Tim Menzen, Coriolis Pharma, M眉nchen
鈥淚nnovative Technologies and Analytical Challenges during Biopharmaceutical Drug Product Development鈥�
Place: N27, Time: 15h00
19th of July 2021
Prof. Sebastian Wiese, Ulm University
鈥淢ass spectrometry based identification and characterization of bioactive peptides current state and future developments鈥�
Place: N27, Time: 15h00
5th of July 2021
Prof. Daniel Garc铆a Rivera, University of Havana, Cuba
鈥淢ulticomponent functionalization of peptides and protein for therapeutics and vaccine development鈥�
Place: N27, Time: 15h00
15th of March 2021
Prof. Galit Alter, Ragon Institute of MGH, MIT and Harvard
鈥淪ystems Serology to Define Correlates of Immunity to SARS-CoV-2鈥�
Place: Online (Webex), Time: 15h00
1st of March 2021
Prof. Ulf Dittmer, Universit盲tsklinikum Essen
鈥淭he anti-viral activity of Interferon alpha subtypes鈥�
Place: Online (Webex), Time: 15h00
22nd of February 2021
CRC 1279 Monday Seminar series with Prof. Melpomeni Fani, University Hospital Basel
鈥淧eptide-based radiotheranostics in oncology鈥�
Place: Online (Webex), Time: 15h00
25th of January 2021
CRC 1279 Monday Seminar series with Prof. Renate K枚nig, Paul-Ehrlich-Institut, Langen
鈥淩egulation of SAMHD1 at the crossroads of autoinflammation, virus inhibition and cancer鈥�
Place: Online (Webex), Time: 15h00